Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 12.7.2024G.V.Pharma, a.s. (GVP)51015V PNC 500 (tbl flm 30x500 mg (blister))15.7.2024R
 4.7.2024Viatris Limited (VIM)31393Galantamin Viatris 16 mg (cps pld 28x16 mg (blis.Al/Al))15.7.2024R
 12.7.2024Menarini International Operations Luxembourg S.A. (MNR)04073Omarit (tbl 10x20 mg (blis.PA/Al/PVC/Al))15.7.2024O
 29.5.2024ratiopharm GmbH (RAT)35321Perindopril-ratiopharm 4 mg (tbl 30x4 mg (blis.PVC/PE/PVDC/Al))15.7.2024R
 12.7.2024G.V.Pharma, a.s. (GVP)51019V PNC 750 (tbl flm 30x750 mg (blister))15.7.2024R
 12.7.2024G.V.Pharma, a.s. (GVP)51018V PNC 750 (tbl flm 20x750 mg (blister))15.7.2024R
 9.7.2024Zentiva, k.s. (ZNT-1)5023DPenlac 500 mg/125 mg (tbl flm 21x500 mg/125 mg (blis.OPA/Al/PVC/Al))15.7.2024O
 9.7.2024Upjohn EESV (UPO-NL)62569Norvasc 5 mg tablety (tbl 30x5 mg (blis.PVC/PVDC/Al))15.7.2024O
 14.5.2024Pfizer Europe MA EEIG (PFI-BE-3)93860DIFLUCAN 150 mg (cps dur 1x150 mg (blis.PVC/Al-priehľ.))15.7.2024R
 10.5.2024Teva B.V. (TEV-NL-4)8233CSunitinib Teva 12,5 mg tvrdé kapsuly (cps dur 30x1x12,5 mg (blis.PVC/Aclar/PVC/Al))15.7.2024R
 25.6.2024Olikla s.r.o. (OLK)2375DLatanoprost/timolol Olikla 0,05 mg/ml + 5 mg/ml očné roztokové kvapky (int opo 1x2,5 ml (fľ.LDPE))15.7.2024R
 10.5.2024Teva B.V. (TEV-NL-4)8238CSunitinib Teva 25 mg tvrdé kapsuly (cps dur 30x1x25 mg (blis.PVC/Aclar/PVC/Al))15.7.2024R
 9.5.2024Novartis Europharm Limited (NEH-IE)20582Votrient 200 mg filmom obalené tablety (tbl flm 90x200 mg (fľ.HDPE))15.7.2024Z
 12.7.2024G.V.Pharma, a.s. (GVP)51023V PNC 1000 (tbl flm 30x1000 mg (blister))15.7.2024R
 12.7.2024Exeltis Slovakia s.r.o. (EET)7917DIvermectin Exeltis 3 mg tablety (tbl 10x3 mg (blis.Al/Al))12.7.2024Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To